17 /100
LOW RISK
Score updated Jul 13, 2026

CWAN — Clearwater Analytics Holdings, Inc. Dilution Risk Tracker

Track CWAN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CWAN — Get alerts when the score changes →

As of July 13, 2026, Clearwater Analytics Holdings, Inc. (CWAN) has a DilutionWatch DilutionScore of 17/100, rated LOW dilution risk. Clearwater Analytics Holdings, Inc. has a market capitalization of $7.27B, 297.38M shares outstanding, 337 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CWAN.
🔔 Track CWAN — Get forecast alerts →

💹 Market Data

Market Cap$7.27B
Shares Outstanding297.38M
Float293.92M
Cash$81.51M
Debt$806.40M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.6% shares (2026Q1 vs prior)
337 institutional holders · 357.37M shares
#1 BlackRock, Inc. 28.27M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 26.19M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 18.29M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest22.57M
Days to Cover6.6
% of Float7.7%
FINRA data as of Jun 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for CWAN Shareholders

Clearwater Analytics Holdings, Inc. (CWAN) has a DilutionScore of 17/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CWAN shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CWAN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CWAN alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CWAN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CWAN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CWAN
📊 CWAN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CWAN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.